Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT00086502 · COMPLETED

Trial details

NCT number: NCT00086502
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2004-06-01
Primary completion: 2005-11-01
Enrollment: 353

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.